ALISON CARPENTER: Open Payments
NPI 1356851901 · BEVERLY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,526 in 80 payments from 13 companies in 2025. Trend: 2023 $1,834 · 2024 $1,144 · 2025 $1,526
Food & beverage: $1,516Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $396 |
| GENZYME CORPORATION | 9 | $264 |
| Galderma Laboratories, L.P. | 12 | $171 |
| Novartis Pharmaceuticals Corporation | 6 | $137 |
| Lilly USA, LLC | 6 | $135 |
| UCB, Inc. | 3 | $102 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Organon LLC | 4 | $54 |
| STRATA Skin Sciences, Inc. | 5 | $53 |
| Incyte Corporation | 2 | $43 |
Products named: SKYRIZI, DUPIXENT, NEMLUVIO, RINVOQ, TALTZ, Bimzelx, COSENTYX, Sotyktu.
Industry payments across MA — which companies pay providers there.
